Global Primary Biliary Cirrhosis Drug Market 2017 - Research Report By Application, Type, Key Players, Region and Forecast to 2022

 Published Date : Feb-2018   |    Format :PDF |    Number of Pages : 103   |    Publisher : e-Market Research

This report studies Primary Biliary Cirrhosis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AlbireoPharma
    CymaBay Therapeutics, Inc.
    Dr. Falk Pharma GmbH
    Enanta Pharmaceuticals, Inc.
    GlaxoSmithKline Plc
    Intercept Pharmaceuticals, Inc.
    Johnson & Johnson
    MediGene AG
    NGM Biopharmaceuticals, Inc.
    Virobay Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Budesonide
    FFP-104
    GSK-2330672
    MBX-8025
    NGM-282
    Others

By Application, the market can be split into
    Clinic
    Hospital
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2017
1 Industry Overview of Primary Biliary Cirrhosis Drug
    1.1 Definition and Specifications of Primary Biliary Cirrhosis Drug
        1.1.1 Definition of Primary Biliary Cirrhosis Drug
        1.1.2 Specifications of Primary Biliary Cirrhosis Drug
    1.2 Classification of Primary Biliary Cirrhosis Drug
        1.2.1 Budesonide
        1.2.2 FFP-104
        1.2.3 GSK-2330672
        1.2.4 MBX-8025
        1.2.5 NGM-282
        1.2.6 Others
    1.3 Applications of Primary Biliary Cirrhosis Drug
        1.3.1 Clinic
        1.3.2 Hospital
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug
    2.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
    2.4 Industry Chain Structure of Primary Biliary Cirrhosis Drug

3 Technical Data and Manufacturing Plants Analysis of Primary Biliary Cirrhosis Drug
    3.1 Capacity and Commercial Production Date of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016

4 Global Primary Biliary Cirrhosis Drug Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Primary Biliary Cirrhosis Drug Capacity and Growth Rate Analysis
        4.2.2 2016 Primary Biliary Cirrhosis Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Primary Biliary Cirrhosis Drug Sales and Growth Rate Analysis
        4.3.2 2016 Primary Biliary Cirrhosis Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Primary Biliary Cirrhosis Drug Sales Price
        4.4.2 2016 Primary Biliary Cirrhosis Drug Sales Price Analysis (Company Segment)

5 Primary Biliary Cirrhosis Drug Regional Market Analysis
    5.1 North America Primary Biliary Cirrhosis Drug Market Analysis
        5.1.1 North America Primary Biliary Cirrhosis Drug Market Overview
        5.1.2 North America 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.1.4 North America 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
    5.2 China Primary Biliary Cirrhosis Drug Market Analysis
        5.2.1 China Primary Biliary Cirrhosis Drug Market Overview
        5.2.2 China 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.2.4 China 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
    5.3 Europe Primary Biliary Cirrhosis Drug Market Analysis
        5.3.1 Europe Primary Biliary Cirrhosis Drug Market Overview
        5.3.2 Europe 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.3.4 Europe 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
    5.4 Southeast Asia Primary Biliary Cirrhosis Drug Market Analysis
        5.4.1 Southeast Asia Primary Biliary Cirrhosis Drug Market Overview
        5.4.2 Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.4.4 Southeast Asia 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
    5.5 Japan Primary Biliary Cirrhosis Drug Market Analysis
        5.5.1 Japan Primary Biliary Cirrhosis Drug Market Overview
        5.5.2 Japan 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.5.4 Japan 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
    5.6 India Primary Biliary Cirrhosis Drug Market Analysis
        5.6.1 India Primary Biliary Cirrhosis Drug Market Overview
        5.6.2 India 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
        5.6.4 India 2016 Primary Biliary Cirrhosis Drug Market Share Analysis

6 Global 2012-2017E Primary Biliary Cirrhosis Drug Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Primary Biliary Cirrhosis Drug Sales by Type
    6.2 Different Types of Primary Biliary Cirrhosis Drug Product Interview Price Analysis
    6.3 Different Types of Primary Biliary Cirrhosis Drug Product Driving Factors Analysis
        6.3.1 Budesonide of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        6.3.2 FFP-104 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        6.3.3 GSK-2330672 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        6.3.4 MBX-8025 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        6.3.5 NGM-282 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        6.3.6 Others of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis

7 Global 2012-2017E Primary Biliary Cirrhosis Drug Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Primary Biliary Cirrhosis Drug Consumption by Application
    7.2 Different Application of Primary Biliary Cirrhosis Drug Product Interview Price Analysis
    7.3 Different Application of Primary Biliary Cirrhosis Drug Product Driving Factors Analysis
        7.3.1 Clinic of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        7.3.2 Hospital of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
        7.3.3 Others of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Primary Biliary Cirrhosis Drug
    8.1 AlbireoPharma
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AlbireoPharma 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AlbireoPharma 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.2 CymaBay Therapeutics, Inc.
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 CymaBay Therapeutics, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 CymaBay Therapeutics, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.3 Dr. Falk Pharma GmbH
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Dr. Falk Pharma GmbH 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Dr. Falk Pharma GmbH 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.4 Enanta Pharmaceuticals, Inc.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Enanta Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Enanta Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.5 GlaxoSmithKline Plc
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 GlaxoSmithKline Plc 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 GlaxoSmithKline Plc 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.6 Intercept Pharmaceuticals, Inc.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Intercept Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Intercept Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.7 Johnson & Johnson
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Johnson & Johnson 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Johnson & Johnson 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.8 MediGene AG
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 MediGene AG 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 MediGene AG 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.9 NGM Biopharmaceuticals, Inc.
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 NGM Biopharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 NGM Biopharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
    8.10 Virobay Inc.
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Virobay Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Virobay Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis

9 Development Trend of Analysis of Primary Biliary Cirrhosis Drug Market
    9.1 Global Primary Biliary Cirrhosis Drug Market Trend Analysis
        9.1.1 Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Primary Biliary Cirrhosis Drug Sales Price Forecast
    9.2 Primary Biliary Cirrhosis Drug Regional Market Trend
        9.2.1 North America 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
        9.2.2 China 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
        9.2.3 Europe 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
        9.2.5 Japan 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
        9.2.6 India 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
    9.3 Primary Biliary Cirrhosis Drug Market Trend (Product Type)
    9.4 Primary Biliary Cirrhosis Drug Market Trend (Application)

10 Primary Biliary Cirrhosis Drug Marketing Type Analysis
    10.1 Primary Biliary Cirrhosis Drug Regional Marketing Type Analysis
    10.2 Primary Biliary Cirrhosis Drug International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Primary Biliary Cirrhosis Drug by Region
    10.4 Primary Biliary Cirrhosis Drug Supply Chain Analysis

11 Consumers Analysis of Primary Biliary Cirrhosis Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures
    Figure Picture of Primary Biliary Cirrhosis Drug
    Table Product Specifications of Primary Biliary Cirrhosis Drug
    Table Classification of Primary Biliary Cirrhosis Drug
    Figure Global Production Market Share of Primary Biliary Cirrhosis Drug by Type in 2016
    Figure Budesonide Picture
    Table Major Manufacturers of Budesonide
    Figure FFP-104 Picture
    Table Major Manufacturers of FFP-104
    Figure GSK-2330672 Picture
    Table Major Manufacturers of GSK-2330672
    Figure MBX-8025 Picture
    Table Major Manufacturers of MBX-8025
    Figure NGM-282 Picture
    Table Major Manufacturers of NGM-282
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Primary Biliary Cirrhosis Drug
    Figure Global Consumption Volume Market Share of Primary Biliary Cirrhosis Drug by Application in 2016
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Primary Biliary Cirrhosis Drug by Regions
    Figure North America Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Figure China Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Figure Europe Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Figure Japan Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Figure India Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
    Table Primary Biliary Cirrhosis Drug Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug in 2016
    Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
    Figure Industry Chain Structure of Primary Biliary Cirrhosis Drug
    Table Capacity and Commercial Production Date of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Primary Biliary Cirrhosis Drug 2012-2017
    Figure Global 2012-2017E Primary Biliary Cirrhosis Drug Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Primary Biliary Cirrhosis Drug Market Size (Value) and Growth Rate
    Table 2012-2017E Global Primary Biliary Cirrhosis Drug Capacity and Growth Rate
    Table 2016 Global Primary Biliary Cirrhosis Drug Capacity (K Pcs) List (Company Segment)
    Table 2012-2017E Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate
    Table 2016 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) List (Company Segment)
    Table 2012-2017E Global Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Table 2016 Global Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E 
    Figure North America 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Figure North America 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E 
    Figure China 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) 
    Figure China 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
    Figure Europe 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Figure Europe 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
    Figure Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Figure Southeast Asia 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
    Figure Japan 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Figure Japan 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
    Figure India 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
    Figure India 2016 Primary Biliary Cirrhosis Drug Sales Market Share
    Table Global 2012-2017E Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type
    Table Different Types Primary Biliary Cirrhosis Drug Product Interview Price
    Table Global 2012-2017E Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application
    Table Different Application Primary Biliary Cirrhosis Drug Product Interview Price
    Table AlbireoPharma Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 AlbireoPharma Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 AlbireoPharma Primary Biliary Cirrhosis Drug Business Region Distribution
    Table CymaBay Therapeutics, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
    Table Dr. Falk Pharma GmbH Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Business Region Distribution
    Table Enanta Pharmaceuticals, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
    Table GlaxoSmithKline Plc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Business Region Distribution
    Table Intercept Pharmaceuticals, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
    Table Johnson & Johnson Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Johnson & Johnson Primary Biliary Cirrhosis Drug Business Region Distribution
    Table MediGene AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 MediGene AG Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 MediGene AG Primary Biliary Cirrhosis Drug Business Region Distribution
    Table NGM Biopharmaceuticals, Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
    Table Virobay Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Virobay Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Virobay Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
    Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (K Pcs) and Growth Rate Forecast
    Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Forecast
    Figure North America 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure China 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Europe 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Japan 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure India 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Table Global Sales Volume (K Pcs) of Primary Biliary Cirrhosis Drug by Type 2017-2022
    Table Global Consumption Volume (K Pcs) of Primary Biliary Cirrhosis Drug by Application 2017-2022
    Table Traders or Distributors with Contact Information of Primary Biliary Cirrhosis Drug by Region